O. Marcy

发表

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

S. Vong, Y. Madec, J. Delfraissy, 2011, The New England journal of medicine.

Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial

Q. Bassat, J. Sacarlal, T. Mvalo, 2019, Trials.

Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial)

Y. Madec, F. Blanc, E. Nerrienet, 2014, PloS one.

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis

C. Delaugerre, S. Eholie, E. Messou, 2022, Open forum infectious diseases.

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial.

C. Delaugerre, S. Eholie, E. Messou, 2021, The Lancet. Infectious diseases.

Plasma Concentrations of Efavirenz with a 600 Mg Standard Dose in Cambodian HIV-Infected Adults Treated for Tuberculosis with a Body Weight above 50 Kg

Y. Madec, F. Blanc, Monidarin Chou, 2013, Antiviral therapy.

Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study.

C. Delacourt, S. Blanche, P. Msellati, 2017, The lancet. HIV.

Fluoroquinolone resistance and Mycobacterium tuberculosis: CAP guidelines play an important role.

J. van Griensven, B. Rammaert, A. Tarantola, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.

Y. Madec, J. Delfraissy, F. Blanc, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tuberculosis in children with severe acute malnutrition

P. Vaz, Kendra K. Radtke, A. Garcia-Prats, 2022, Expert review of respiratory medicine.

Laboratory development of a simple stool sample processing method diagnosis of pediatric tuberculosis using Xpert Ultra.

M. Nicol, S. Eyangoh, S. Godreuil, 2020, Tuberculosis.

Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children.

C. Delacourt, S. Eyangoh, S. Godreuil, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia

J. Delfraissy, A. Canestri, Olivier Ségéral, 2016, PloS one.

TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB

V. Haridas, Y. Madec, J. Delfraissy, 2015, AIDS.

Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis.

D. Scott‐Algara, Y. Madec, F. Barré-Sinoussi, 2012, Blood.

patients with tuberculosis immune reconstitution inflammatory syndrome (IRIS) in HIV-infected Natural killer cell degranulation capacity predicts early onset of the

D. Scott‐Algara, Y. Madec, F. Barré-Sinoussi, 2012 .

High Activation of (cid:13)(cid:14) T Cells and the (cid:13)(cid:14) 2pos T-Cell Subset Is Associated With the Onset of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, ANRS 12153 CAPRI NK

Y. Madec, L. Weiss, D. Laureillard, 2020 .

High Activation of γδ T Cells and the γδ2pos T-Cell Subset Is Associated With the Onset of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, ANRS 12153 CAPRI NK

D. Scott‐Algara, Y. Madec, F. Barré-Sinoussi, 2019, Front. Immunol..

Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low‐ and middle‐income countries

M. Yotebieng, L. Diero, T. Sterling, 2019, Journal of the International AIDS Society.

Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries

M. Egger, M. Yotebieng, L. Otero, 2022, PLOS global public health.

Paediatric tuberculosis - new advances to close persistent gaps.

R. Triasih, A. Mandalakas, F. Amanullah, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis

C. Delacourt, G. Carcelain, S. Godreuil, 2019, Pediatrics.

Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial

C. Delacourt, V. Mulenga, S. Godreuil, 2021, BMC Pediatrics.

Co-infection tuberculose et VIH - Coordination d’un essai clinique randomisé par l’Institut Pasteur du Cambodge

E. Nerrienet, L. Borand, C. Leng, 2013 .

TB-IRIS and remodelling of the T-cell compartment in highly immunosuppressed HIV+ patients with TB

V. Haridas, Y. Madec, J. Delfraissy, 2014 .

Development of a Clinical Prediction Score Including Monocyte-to-Lymphocyte Ratio to Inform Tuberculosis Treatment Among Children With HIV: A Multicountry Study

Irene N Njuguna, T. Lash, M. Becerra, 2022, Open forum infectious diseases.

Acceptability of decentralizing childhood tuberculosis diagnosis in low-income countries with high tuberculosis incidence: experiences and perceptions from health care workers in sub-Saharan Africa and South-East Asia

S. Kaing, E. Wobudeya, R. Moh, 2023, medRxiv.